DK0549742T3 - Anvendelse af CANP-inhibitorer i farmaceutiske præparater - Google Patents
Anvendelse af CANP-inhibitorer i farmaceutiske præparaterInfo
- Publication number
- DK0549742T3 DK0549742T3 DK92911432T DK92911432T DK0549742T3 DK 0549742 T3 DK0549742 T3 DK 0549742T3 DK 92911432 T DK92911432 T DK 92911432T DK 92911432 T DK92911432 T DK 92911432T DK 0549742 T3 DK0549742 T3 DK 0549742T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitors
- therapy
- contraception
- neutral
- viral diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- AIDS & HIV (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR91100238 | 1991-06-03 | ||
| PCT/EP1992/001223 WO1992021373A1 (en) | 1991-06-03 | 1992-06-02 | USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0549742T3 true DK0549742T3 (da) | 2004-07-26 |
Family
ID=10940713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92911432T DK0549742T3 (da) | 1991-06-03 | 1992-06-02 | Anvendelse af CANP-inhibitorer i farmaceutiske præparater |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0549742B1 (da) |
| JP (1) | JP3703828B2 (da) |
| AT (1) | ATE263574T1 (da) |
| AU (1) | AU646961B2 (da) |
| CA (1) | CA2088671C (da) |
| DE (1) | DE69233337T2 (da) |
| DK (1) | DK0549742T3 (da) |
| ES (1) | ES2215162T3 (da) |
| GR (1) | GR1001044B (da) |
| IL (1) | IL102079A (da) |
| NO (1) | NO930305L (da) |
| NZ (1) | NZ243003A (da) |
| PT (1) | PT100560A (da) |
| WO (1) | WO1992021373A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL307864A1 (en) * | 1992-09-09 | 1995-06-26 | Synergen Inc | Retroviral infection inhibition |
| US5607831A (en) * | 1993-03-25 | 1997-03-04 | The United States Of America As Represented By The Department Of Health And Human Services | In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death |
| EP0626178A1 (de) * | 1993-05-17 | 1994-11-30 | Ciba-Geigy Ag | Verwendung von Hemmstoffen von HIV-Aspartatproteasen zur Bekämpfung von Tumorerkrankungen |
| US20030060435A1 (en) | 1994-05-31 | 2003-03-27 | Serge Carillo | Method of cancer treatment by p53 protein control |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8815962D0 (en) * | 1988-07-05 | 1988-08-10 | Univ London | Pharmaceutical preparation & method for promoting reinnervation of muscle fibers |
-
1991
- 1991-06-03 GR GR910100238A patent/GR1001044B/el not_active IP Right Cessation
-
1992
- 1992-06-01 PT PT100560A patent/PT100560A/pt not_active Application Discontinuation
- 1992-06-02 ES ES92911432T patent/ES2215162T3/es not_active Expired - Lifetime
- 1992-06-02 IL IL10207992A patent/IL102079A/en not_active IP Right Cessation
- 1992-06-02 DK DK92911432T patent/DK0549742T3/da active
- 1992-06-02 EP EP92911432A patent/EP0549742B1/en not_active Expired - Lifetime
- 1992-06-02 CA CA002088671A patent/CA2088671C/en not_active Expired - Fee Related
- 1992-06-02 DE DE69233337T patent/DE69233337T2/de not_active Expired - Fee Related
- 1992-06-02 AT AT92911432T patent/ATE263574T1/de not_active IP Right Cessation
- 1992-06-02 AU AU19073/92A patent/AU646961B2/en not_active Ceased
- 1992-06-02 JP JP51122392A patent/JP3703828B2/ja not_active Expired - Fee Related
- 1992-06-02 WO PCT/EP1992/001223 patent/WO1992021373A1/en active IP Right Grant
- 1992-06-03 NZ NZ243003A patent/NZ243003A/en not_active IP Right Cessation
-
1993
- 1993-01-29 NO NO93930305A patent/NO930305L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT100560A (pt) | 1993-07-30 |
| AU1907392A (en) | 1993-01-08 |
| DE69233337T2 (de) | 2005-05-04 |
| NO930305L (no) | 1993-02-26 |
| NO930305D0 (no) | 1993-01-29 |
| DE69233337D1 (de) | 2004-05-13 |
| GR1001044B (el) | 1993-04-28 |
| NZ243003A (en) | 1997-07-27 |
| IL102079A (en) | 1996-10-16 |
| EP0549742A1 (en) | 1993-07-07 |
| JP3703828B2 (ja) | 2005-10-05 |
| EP0549742B1 (en) | 2004-04-07 |
| JPH06502188A (ja) | 1994-03-10 |
| CA2088671C (en) | 1997-01-14 |
| AU646961B2 (en) | 1994-03-10 |
| ATE263574T1 (de) | 2004-04-15 |
| CA2088671A1 (en) | 1992-12-04 |
| ES2215162T3 (es) | 2004-10-01 |
| WO1992021373A1 (en) | 1992-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0316234A (pt) | Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos | |
| ES2051641B1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
| TR199903053T2 (xx) | Benzimidazol t�revleri. | |
| NO971889D0 (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| DK0725790T3 (da) | Substituerede tetra- og pentapeptidinhibitorer af proteinfarnesyltransferase | |
| BR0009670A (pt) | Métodos de induzir morte de células de câncer e regressão de tumor | |
| NO952132L (no) | Farmakologiske aktive pyridin-derivater og deres fremstilling | |
| BR0013281A (pt) | Derivados de arilmetil-carbonilamino-tiazol, processo para sua preparação e seu uso como agentes antitumorais | |
| BG101118A (en) | Therapeutical compounds | |
| CY1107351T1 (el) | Καινοφανης μεταλλαγμενη μορφη απιμινασης αργινινης | |
| PT979244E (pt) | Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem | |
| BR0315337A (pt) | Composto, formulação farmacêutica, e, método para tratar câncer | |
| ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
| DK0516588T3 (da) | Substituerede diaminophthalimider og analoger | |
| BR9910032A (pt) | Tienopirimidinas | |
| BR9909087A (pt) | Formulações para proteção de conjugados peg-alfa interferon | |
| BR0011778A (pt) | Tienopirimidinas | |
| DE58909850D1 (de) | Arzneimittel zur behandlung von krebs, aids und viruserkrankungen | |
| DK0549742T3 (da) | Anvendelse af CANP-inhibitorer i farmaceutiske præparater | |
| TR200103457T2 (tr) | 4-Fenil-Pirimidin Türevleri. | |
| EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
| BR0010084A (pt) | Composição farmacêutica, processos para prevenir, tratar ou inibir o desenvolvimento de retinopatia simples ou retinopatia proliferativa, e para aumentar potencial retiniano ou edema retiniano de mamìfero, e, uso de um composto | |
| DE3786456T2 (de) | Kombinationen von nekrose-tumor-faktoren und entzündungshemmenden mitteln für die behandlung von bösartigen und nicht bösartigen erkrankungen. | |
| NO20050067L (no) | Pegylert T1249 polypeptid | |
| ES2013342A6 (es) | Procedimiento para preparar composiciones farmaceuticas a base de ingredientes seleccionados principalmente entre alcohol, fenol, polvo de cantarida, yodo y fosforo. |